 |
Drug Development and Drug
Interactions: Publications
2006
- Lei Zhang, John M. Strong, Wei Qiu, Lawrence J. Lesko, and Shiew-Mei Huang. Scientific Perspectives on Drug Transporters and Their Role in Drug Interactions [PDF] [external link] Mol Pharm. 2006; 3(1), 62-69, Epub
Jan 4 2006.
2005
- Andersson, T, Flockhart, DA, Goldstein, DB, Huang, S-M, Kroetz, D, Milos, P, Ratain, M, Thummel, K, Drug metabolizing enzymes- clinical utility of pharmacogenomic test.
Clin Pharmacol Ther. 2005 Dec;78(6):559-81.
[PDF]
- Paine, MF, Ludington, SS, Chen, ML, Stewart, PW, Huang, S-M, Watkins, PB.
Does sex influence proximal small intestinal or p-gp expression? Drug Metab Dispos. 2005 Mar;33(3):426-33. Epub 2004 Dec 17.
2004
- Meadows, M. Preventing serious drug interactions
[HTML] FDA Consumer, July-August 2004
- Huang, S-M, Hall, SD, Watkins, P, Love, LA, Serabjit-Singh, C, Betz, JM,
Hoffman, FA, Honig, P, Coates, PM, Bull, J, Chen, ST, Kearns, GL, Murray, MD. Drug interactions with herbal products & grapefruit
juice: a conference report.
Clin Pharmacol Ther. 2004, 75:1-12.
- Shiew-Mei Huang and Lawrence J. Lesko Drug-drug, drug-dietary supplement, and drug-citrus fruit
and other food interactions — what have we learned? J Clin Pharmacol. 2004; 44:559-569.
[PDF]
- Gorski JC, Huang S-M, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M,
Miller M, Hall, SD. The effect of echinacea on cytochrome p450 activity in vivo. Clin Pharmacol Ther. 2004 Jan;75(1):89-100.
2003
- Advisory Committee for Pharmaceutical Science Clinical Pharmacology Section meeting minutes. April 20-21, 2003 (CYP3A classification and P-gp), Nov 17-18, 2003 (CYP2B6 and CYP2C8) [HTML], November 3, 2004 (Drug interaction concept paper)
[PDF]
- Hall SD, Wang Z, Huang, S-M, Hamman MA, Vasavada N, Adigun AQ,
Hilligoss J, Miller M, Gorski, JC. The interaction between St John’s wort and an oral contraceptive. Clin Pharmacol Ther. 2003 Dec;74(6):525-35.
2002
- Yuan R, Madani S, Wei X, Reynolds K, and Huang S-M. Evaluation of P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions.” Drug Metab Dispos. 2002, Dec;30(12):1311-9. [PDF]
- Wang Z, Hamman MA, Huang S-M, Lesko, LJ, Hall SD. Effect of St John's wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther. 2002 Jun;71(6):414-20.
2001
- Tucker G, Houston JB, and Huang S-M. Optimizing drug development: strategies to assess drug
metabolism/transporter interaction potential — toward a consensus. Clin Pharmacol Ther. 2001 Aug;70(2):103-14; Br J Clin Pharmacol. 2001 Jul;52(1):107-17; Eur J Pharm Sci. 2001 Jul;13(4):417-28; Pharm Res. 2001, Aug;18(8):1071-80.
- Wang Z, Gorski JC, Brater C, Huang S-M, Lesko, LJ, and Hall SD. The effects of St. John’s wort on human cytochrome P450 activity. Clin Pharmacol Ther. 2001 Oct;70(4):317-26.
 Back
to Top 
Back to Drug Interactions
PDF requires the free Adobe
Acrobat Reader
Date created: May 1, 2006 |
|
